Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
In small initial studies, combined kidney and bone marrow transplants from the same donor
have permitted some individuals to stop taking anti-rejection medicines without rejecting
their transplant. This clinical trial will study this method in a greater number of people to
determine if it is indeed effective and safe.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)